Leaflet COLDREX MAX COLD AND COUGH capsules


Indicated for: productive cough; expectoration

Route of administration: oral

Substance: guaifenesin + phenylephrine (expectorant + adrenergic decongestant)

ATC: N02BE51 (Nervous system | Other analgesics and antipyretics | Anilides)

The combination of guaifenesin and phenylephrine is used to relieve cold and flu symptoms, including nasal congestion and productive cough. It combines an expectorant with a nasal decongestant.

Guaifenesin helps thin mucus, making it easier to expel, while phenylephrine reduces nasal congestion by constricting blood vessels in the nasal lining.

This combination is generally well-tolerated but may cause side effects such as dizziness, nausea, insomnia, or increased blood pressure. In rare cases, allergic reactions may occur.

It is important to follow the dosage instructions and avoid long-term use without a doctor's recommendation. Consult a specialist if symptoms persist or worsen.

General data about COLDREX MAX COLD AND COUGH

  • Substance: guaifenesin + phenylephrine
  • Date of last drug list: 01-04-2022
  • Commercial code: W68509001
  • Pharmaceutical form: capsules
  • Quantity: 8
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: OMEGA PHARMA INTERNATIONAL NV - BELGIA
  • Holder: HIPOCRATE 2000 S.R.L. - ROMANIA
  • Number: 14162/2021/01
  • Shelf life: 3 years

Combinations with other substances